深圳信立泰药业股份有限公司

Chinese pharmaceutical company headquartered in Shenzhen, Guangdong and listed on the Shenzhen Stock Exchange under code 002294. Develops, manufactures and sells medicines concentrated in cardiovascular and cerebrovascular disease, with clopidogrel bisulfate tablets as its long-standing flagship product, alongside anti-infectives, orthopaedics and other areas, and has moved into innovative biologics and medical devices with its own research institutes and active ingredient manufacturing.